1 results match your criteria: "and Queen Elizabeth Psychiatric Hospital[Affiliation]"
Patients treated with vigabatrin exhibit central visual function loss.
Epilepsia
November 2002
Neurosciences Research Institute, Aston University, and Queen Elizabeth Psychiatric Hospital, Birmingham, United Kingdom.
Purpose: To investigate visual function in the central 10 degrees in patients who have undergone vigabatrin (VGB) antiepileptic drug (AED) therapy with the aim of identifying a clinical regimen for assessing central visual function.
Methods: The sample comprised 12 epilepsy patients (mean age, 38.6 +/- 11.